2023 Committees

Program Committees

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments. This conference is typically held in the fall.

  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Erin Carducci (Co-Chair), Novartis Pharmaceuticals Corporation
  • Mark Gardner (Co-Chair), Gardner Law, PLLC
  • Heather Banuelos, King & Spalding LLP
  • Dale Cooke, PhillyCooke Consulting
  • Avia Dunn, Skadden, Arps, Slate, Meagher & Flom LLP
  • Mark Gaydos, Sanofi
  • Bryant Godfrey, Foley Hoag
  • Matthew Hegreness, Covington & Burling LLP
  • Christine Humphrey-Antrim, C. Humphrey & Associates, P.A.
  • Danielle C Humphrey, Becton Dickinson (BD)
  • Tina Hu-Rodgers, Buchanan Ingersoll & Rooney PC
  • Michael L. Keech, IQVIA
  • Jae Kim, DLA Piper LLP (US)
  • Brittany Miller, Johnson & Johnson
  • Dominick Paul DiSabatino, Sheppard Mullin Richter & Hampton LLP
  • Heta Zaveri, Opus Regulatory, Inc.

Annual Conference Planning Committee helps plan and implement FDLI’s Annual Conference, the premier event of the food and drug law community. This conference is typically held in the spring.

  • Laura Brown (Staff Liaison), FDLI
  • Jonathan A. Havens (Co-Chair), Saul Ewing Arnstein & Lehr LLP
  • Mantej Nimi Chhina (Co-Chair), BioMarin Pharmaceutical, Inc 
  • Stacy Cline Amin, Morrison and Foerster, LLP
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Jennifer L. Bragg, Skadden, Arps, Slate, Meagher & Flom LLP
  • Karen Day, Pfizer, Inc.
  • Colleen M. Heisey, Jones Day
  • August T. Horvath, Foley Hoag LLP
  • Elizabeth R. Jungman, CDER, FDA
  • Winston S. Kirton, BakerHostetler
  • Chad A. Landmon, Axinn, Veltrop & Harkrider LLP
  • Eric N. Lindblom, O’Neill Institute for National and Global Health Law, Georgetown Law
  • Sharon L. Mayl, DLA Piper LLP
  • Beth G. Oliva, Fox Rothschild LLP
  • Megan L. Olsen, Council for Responsible Nutrition
  • Ann M. Oxenham, CFSAN, FDA
  • Sarah H. Stec, Johnson & Johnson
  • Deborah E. Tolomeo, Spark Therapeutics
  • Anne K. Walsh, Hyman, Phelps & McNamara, PC
  • Lowell M. Zeta, Hogan Lovells US LLP

California Programs Planning Committee helps FDLI identify pertinent topics and develop programming to be offered in California.

  • Khara Minter (Staff Liaison), FDLI
  • Philip George Johnson, IQVIA
  • Melissa Hoffman, Edwards Lifesciences LLC
  • Priya Malavika Mannan, Novartis Pharmaceuticals Corporation
  • Abby Meyer, Sheppard Mullin Richter & Hampton LLP
  • Janet L. Michener Whipple, Validant
  • Kiera Murphy, Latham & Watkins LLP
  • Trenton H. Norris, Arnold & Porter LLP
  • Alexander J. Varond, Goodwin Procter LLP

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance. This conference is typically held in the fall.

  • Laura Brown (Staff Liaison), FDLI
  • Elizabeth Barr Fawell, Hogan Lovells US LLP
  • Brian Burgess, Goodwin Procter LLP
  • Cathy L. Burgess, Alston & Bird LLP
  • Aaron Danzig, Arnall Golden Gregory LLP
  • Gustav W. Eyler, Gibson Dunn & Crutcher LLP
  • Maya P. Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • John C. Garvey, Compliance Architects LLC
  • Jonathan Gil, Pfizer Inc.
  • Perham Gorji, FDA – OC
  • Bryan M. Haynes, Troutman Pepper Hamilton Sanders LLP
  • Bethany Hills, DLA Piper LLP (US)
  • Areta L. Kupchyk, Foley Hoag LLP
  • Peter J. Leininger, King & Spalding LLP
  • Anne K. Miller, Medtronic
  • Sonia W. Nath, Cooley LLP
  • Teresa Park, Covington & Burling LLP
  • Evangelia C. Pelonis, Keller and Heckman LLP
  • Raqiyyah Pippins, Arnold & Porter LLP
  • Ami E. Simunovich, Becton Dickinson (BD)
  • Jessica Tierney, Jones Day 
  • Marta L. Villarraga, Exponent, Inc.
  • Beth P. Weinman, Ropes & Gray LLP

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. This conference is typically held in the fall.

  • Steven Leslie (Staff Liaison), FDLI
  • Stefanie Jill Fogel (Chair), DLA Piper LLP
  • Matthew G. Ball, K&L Gates LLP
  • Ann M. Begley, Wiley LLP
  • Susan M. Bond, Kerry, Inc.
  • Jacqueline J. Chan, Kleinfeld, Kaplan & Becker, LLP
  • Veronica Colas, Hogan Lovells US LLP
  • Sam Dietle, Nestle USA, Inc.
  • Dale Joseph Giali, King & Spalding LLP
  • Jason W. Gordon, Reed Smith LLP
  • Maia C. Kats, Just Food Law
  • Heili Kim, McDermott Will & Emery
  • Joanna Pearce, Haynes and Boone LLP
  • Michael T. Roberts, UCLA School of Law
  • Randal M. Shaheen, BakerHostetler
  • Brian Sylvester, Covington & Burling LLP
  • R. Trent Taylor, McGuireWoods LLP
  • Thomas Tobin, Perkins Coie LLP
  • Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
  • Claudia M. Vetesi, Morrison and Foerster, LLP

Food and Dietary Supplements Safety and Regulation Conference Planning Committee helps FDLI cover recent developments and looming challenges for product safety and regulation. The conference is typically held in the Spring.

  • Bianca Cardona Melendez (Staff Liason), FDLI
  • Neal D. Fortin (Chair), Director, Institute for Food Laws and Regulations, Michigan State University and Professor, Department of Food Science and Human Nutrition, Michigan State University College of Law
  • Amanda D. Cowley, GC &SVP, Legal Strategy and People, U.S. Pharmacopeia
  • Robert Durkin, Of Counsel, Arnall Golden Gregory LLP
  • Andrea G. Ferrenz, Food Law Counsel, Campbell Soup Company
  • Nury Helena Yoo, Counsel, Faegre Drinker Biddle & Reath
  • Marisa Kreider, Principal Science Advisor, Cardno ChemRisk
  • Deepti A. Kulkarni, Partner, Covington & Burling LLP
  • Stuart M. Pape, Senior Partner and Chair, FDA Practice, Polsinelli PC
  • Amaru J.Sánchez, Associate, Wiley Rein LLP
  • Maged Sharaf, Senior Director for Labeling, Cannabis, and Claims, EAS Consulting Group
  • Sarah Sorscher, Deputy Director of Regulatory Affairs, Center for Science in the Public Interest
  • Jack Wenik, Member of the Firm, Epstein Becker & Green P.C.

New to Food and Drug Law Planning Committee assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Bianca N. Cardona Melendez (Staff Liaison), FDLI
  • Kathryn Culver, Latham & Watkins LLP
  • Laura Dona, Arnall Golden Gregory LLP
  • Anthony Fanucci, Alston & Bird LLP
  • Lauren Farruggia, Goodwin Procter LLP
  • Jaclyn Fonteyne, Sidley Austin LLP
  • Elizabeth A. Gallenagh, Healthcare Distribution Alliance (HDA)
  • Seth Gitner, Saul Ewing Arnstein & Lehr LLP
  • Coleen Hill, Duane Morris LLP
  • Samantha Hong, Kleinfeld, Kaplan & Becker, LLP
  • Maria Kalousi-Tatum, Morgan, Lewis & Bockius LLP
  • Celeste A. Letourneau, Reed Smith LLP
  • George A. O’Brien, Mayer Brown LLP
  • Laura Pence, Leavitt Partners, LLC
  • Jessica Ringel, King & Spalding LLP
  • Omar Robles, Harvard University
  • Carly Rolph, Steptoe & Johnson LLP
  • Kelsey Tavares, DLA Piper LLP (US)

Patient Organization Engagement Committee assists FDLI by creating innovative introductory course offerings for patient organizations.

  • Paige Samson (Staff Liaison), FDLI
  • Mitchell Berger, FDA – CBER
  • Ryan Matthew Hohman, Friends of Cancer Research
  • Kira Jabri, EMMA International
  • Susan S. Lee, Goodwin Procter LLP
  • Katherine Maynard, Peterson Wilmarth and Robertson, LLP (PWR)
  • Christopher M. Mikson, DLA Piper LLP (US)
  • Natalie Oehlers, Buchanan Ingersoll & Rooney PC
  • Amirala Pasha, Mayo Clinic
  • Peter Pitts, Center for Medicine in the Public Interest
  • James E. Valentine, Hyman, Phelps & McNamara, PC
  • Jessica Vaughn, Wiley LLP
  • David Zook, Faegre Drinker Biddle & Reath LLP

Webinar Programs Committee advises FDLI in formulating and implementing webinars about law, regulation and policy affecting food and dietary supplements, tobacco and nicotine, and medical products.

  • Khara Minter (Staff Liaison), FDLI
  • Stephanie Agu, Hogan Lovells US LLP
  • Nathan A. Beaver, Foley & Lardner LLP
  • Barbara A. Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Hannah Bornstein, Nixon Peabody
  • Jennifer A. Davidson, Kleinfeld, Kaplan & Becker, LLP
  • Lauren Farruggia, Goodwin Procter LLP
  • Mark Hendrickson, Leavitt Partners, LLC
  • Joshua Oyster, Ropes & Gray LLP
  • Lee Rosebush, Baker Hostetler
  • Tony Subketkaew, Haynes and Boone LLP

Publications Committees

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field.

  • Paige Samson (Staff Liaison), FDLI
  • Meryl E Bartlett, Latham & Watkins LLP
  • Kayla Cristales, Haynes and Boone LLP
  • Madeleine Giaquinto, Greenleaf Health, Inc.
  • Jennifer Kang, Otsuka America Pharmaceutical, Inc.
  • Elizabeth Mulkey, Goodwin Procter LLP
  • Matthew Piscitelli, DLA Piper LLP (US)
  • Mariam Sarwar, Crowell & Moring LLP
  • Jennifer Stonecipher Hill, Shook, Hardy & Bacon LLP

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions, advises on content, and serves as a resource for our student editors at Georgetown University Law Center.

  • Paige Samson (Staff Liaison), FDLI
  • Nathan A. Beaton, Latham & Watkins LLP
  • Laurie J. Beyranevand, Vermont Law School
  • Brigid Bondoc, Morrison and Foerster, LLP
  • Marie Boyd, University of South Carolina School of Law
  • Nathan A. Brown, Akin Gump Strauss Hauer & Feld LLP
  • Christine P. Bump, Penn Avenue Law & Policy
  • Jonathan M. Cohen, K&L Gates LLP
  • Michelle Divelbiss, Covington & Burling LLP
  • Bridget C.E. Dooling, George Washington University
  • Jamie W. Gamerman, FDA – CDER
  • Lewis A. Grossman, American University
  • Emily C. Helms Williams, FDA – OC
  • Peter Barton Hutt, Covington & Burling LLP
  • William M. Janssen, Charleston School of Law
  • John F. Johnson III, Shook, Hardy & Bacon LLP
  • Alan C. Katz, toXcel, LLC
  • Geoffrey M. Levitt, DLA Piper LLP (US)
  • Peter V. Lindsay, Paul Hastings, LLP
  • Markham C. Luke, FDA – CDER
  • Catherine A. Melfi, Omeros Corporation
  • Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
  • Alan G. Minsk (Chair), Arnall Golden Gregory LLP
  • Adam Muchmore, Penn State Law
  • James O’Reilly, University of Cincinnati
  • Daniel Orr, Thomson Reuters Inc.
  • Somnath Pal, St. John’s University College of Pharmacy
  • Tyler Scandalios, Arnold & Porter LLP
  • Shy Shorer, NIH, NCI, CCR
  • David Simon, Harvard Law School
  • Anna Sims, FDA – OC
  • Eric Solowey, Parexel International Corporation
  • Andrew Wasson, Haug Partners LLP
  • Emily Wright, Pfizer Inc.

Publications and Academic Programs Committee helps identify areas for scholarly programming and provides high-level recommendations for all of FDLI’s publications, including updating essential references and generating content for new book resources.

  • Paige Samson (Staff Liaison), FDLI
  • Kalah Auchincloss, Greenleaf Health, Inc.
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Victor Krauthamer, George Washington University
  • Laurie Lenkel, FDA – OC
  • Jordan K. Paradise, Loyola University – Chicago
  • Amy Speros, Latham & Watkins LLP
  • Karen Zhou, Northeastern University

Publications Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters.

  • Paige Samson (Staff Liaison), FDLI
  • Vanessa Burrows, Simpson Thacher & Bartlett
  • Jennifer Fulford, toXcel, LLC
  • Stephanie M. Haggerty, Pfizer Inc.
  • Rouget Frederic Henschel, Potomac Law Group, PLLC
  • Emily Hussey, Reed Smith LLP
  • Gail Javitt, Hyman, Phelps & McNamara, PC
  • Justine E. Lenehan, Kleinfeld, Kaplan & Becker, LLP
  • Elise Lewis, Otsuka America Pharmaceutical, Inc
  • Eileen McMahon, Torys LLP
  • Tina Papagiannopoulos, Foley Hoag LLP
  • Melissa B. Runsten, Debevoise & Plimpton, LLP
  • Emily Sachs, Latham & Watkins LLP
  • Marc Wagner, BakerHostetler

Product Area Committees

Cannabis-Derived Products Committee assists FDLI with developing content and identifying stakeholders to contribute to the discussion of cannabis-derived products in the federal regulatory space.

  • Steven Leslie (Staff Liaison), FDLI
  • Donald R. Becker, Turning Point Brands, Inc.
  • Angela Betancourt, FDA – CVM
  • Bill Bookout, National Animal Supplement Council
  • Daniel Charles Rubenstein, Steptoe & Johnson LLP
  • Marshall A. Custer, Husch Blackwell LLP
  • T. Daniel Logan, Kleinfeld, Kaplan & Becker, LLP
  • William Garvin, Buchanan Ingersoll & Rooney PC
  • Kate W. Hardey, McGuireWoods LLP
  • Jensen Jose, Center for Science in the Public Interest
  • Andrew Kline, Perkins Coie LLP
  • Kyrsten Melander, FDA – OC
  • Deborah Miran, DMiran Consulting
  • Eliza Muse, Alaska Department of Health and Social Services
  • Michele Nakata, Hawaii Department of Health
  • Heike Newman, University of Colorado
  • Evelina Norwinski, Arnold & Porter LLP
  • Shawn “Pepper” Roussel, Green Pepper Solutions
  • Nandakumara D. Sarma, U.S. Pharmacopeia
  • Danielle Smith, Roswell Park Cancer Institute
  • Frederick A. Stearns, Keller and Heckman
  • Brian Yagi, Johns Hopkins University

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.

  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Sangeeta Abraham, Exponent, Inc.
  • Christina Anderson Mooney, Medtronic
  • M. Jason Brooke, Brooke & Associates
  • Shelby Buettner, Becton Dickinson (BD)
  • Lola Fashoyin-Aje, FDA – CDER
  • James C. Fraser, Greenberg Traurig, LLP
  • Ernest Fung, Cardno ChemRisk
  • Kelly Goldberg, PhRMA
  • Elizabeth Guo, FDA – OC
  • Margo Heath-Chiozzi, Celldex Therapeutics, Inc.
  • Carmine Jabri, EMMA International
  • Jeremiah Kelly, US Army Med Research Institute of Infectious Diseases
  • John D. Kendzior, Reed Smith LLP
  • Marian J. Lee, Gibson Dunn & Crutcher LLP
  • Brian J. Malkin, McDermott Will & Emery
  • William A. McConagha, Skadden, Arps, Slate, Meagher & Flom LLP
  • Andrew Papas, NSF International
  • Elizabeth Richards, Latham & Watkins LLP
  • Laurence Rickles, TEVA Pharmaceuticals USA, Inc.
  • Lance L. Shea, BakerHostetler
  • Howard R. Sklamberg, Arnold & Porter LLP
  • Eva Temkin, King & Spalding LLP
  • Stuart TenHoor, Stuart TenHoor Legal Search
  • Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.

  • Steven Leslie (Staff Liaison), FDLI
  • Tony Abboud, Vapor Technology Association
  • Jasjit Ahluwalia, Brown University
  • Aruni Bhatnagar, University of Louisville School of Medicine
  • Shelly Blackwell, EAS Consulting Group
  • Brittani Cushman, Turning Point Brands, Inc
  • Clifford E. Douglas, University of Michigan
  • Connor Fuchs, Campaign for Tobacco-Free Kids
  • Joe G. Gitchell, Pinney Associates, Inc.
  • Matthew R. Holman, Philip Morris International
  • Eshael Johnson, FDA
  • Rima Khoury, Fumari, Inc.
  • Jaron King, South Carolina Department of Health and Environmental Control
  • John L Marshall , Altria Client Services LLC
  • Daniel P. McGee, Keller and Heckman
  • William A. McGrath, Potomac Law Group
  • Brian J. Miller, Johns Hopkins University
  • Stefanie Miller, JUUL Labs
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • John Pritchard, 22nd Century Group, Inc.
  • Agustin Rodriguez, Troutman Pepper Hamilton Sanders LLP
  • Henry Roemer, Finger, Roemer, Brown & Mariani LLP
  • Barry Schaevitz, Fox Rothschild LLP
  • Jim Solyst, JMS Scientific Engagement
  • Mark J. Vaders, Womble Bond Dickinson (US) LLP
  • Lauren Caroline Tadros Potter (Staff Liaison), FDLI
  • Stephanie Batliner, Chairperson, Generic Animal Drug Alliance
  • Elizabeth Butterworth Stutts, Elizabeth Butterworth Stutts, Esq, PLLC
  • Margitta Dziwenka, Director, Preclinical and Companion Animal Services, Nutrasource Pharmaceutical & Nutraceutical Services
  • Laura R. Epstein, CVM, FDA
  • Patrick C. Gallagher, Duane Morris LLP
  • Grace Gowda, International Biomedical Regulatory Sciences, University of Georgia

Governance Committees

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors.

*This committee is not seeking applications for 2022

  • Hayley Carpenter (Staff Liaison), FDLI
  • Cathy L. Burgess (Chair), Alston & Bird LLP
  • Neil P. Di Spirito, Epstein Becker & Green, PC
  • Jonathan A. Havens, Saul Ewing Arnstein & Lehr LLP
  • Stuart M. Pape, Polsinelli PC

Diversity, Equity, and Inclusion Advisory Committee advises FDLI on substantive and programmatic issues relevant to diversity, equity, and inclusion with a focus on promoting greater representation of Black professionals in the food and drug law community.

  • Benjamin Butz (Staff Liaison), FDLI
  • Elizabeth H. Anderson, FDA – CFSAN
  • Oluwaseun (Kemi) Asante, FDA – CDER
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Joseph D. Cohen, Porter Hedges LLP
  • L’Tonya Davis, FDA – OC
  • Kristina DiPano, McDermott Will & Emery
  • Javier Gonzalez Rivera, Arnold & Porter LLP
  • Hilary Hoffman, DLA Piper LLP (US)
  • Barbara Jones-Binns, Alston & Bird LLP
  • Kristin M. Kaplan, Shook, Hardy & Bacon LLP
  • Daniel Kracov, Arnold & Porter LLP
  • Tim Lombardo, EAS Consulting Group
  • Flora Chinyere Okereke, RAI Service Company (RAISC) (Reynolds American Inc.)
  • Mariam Sarwar, Crowell & Moring LLP
  • John (Barr) Weiner, FDA – OC
  • Madison Wheeler, EMMA International

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors.

*This committee is not seeking applications for 2022

  • Hayley Carpenter (Staff Liaison), FDLI
  • Frederick R. Ball (Chair), Duane Morris LLP
  • Jeffrey K. Francer, Association for Accessible Medicines
  • Jeffrey N. Gibbs, Hyman, Phelps & McNamara, PC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search